Parabilis Medicines
$28.32
4
-$0.38-1.32%Friday 20:00
+$0.00+0%Friday 22:00After hours
Statistics
Day High
28.37
Day Low
28.32
52W High
42.49
52W Low
22.66
Volume
44,618
Avg. Volume
-
Mkt Cap
3.5B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q1 2026
Q2 2026
Next
-2.32
-1.6
-0.88
-0.17
Expected EPS
-0.36
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-186.93MNet Income
Analyst Ratings
$41.67Average Price Target
The highest estimate is 45.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PBLS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Show More
CEO
Mathai Mammen
Employees
145
Country
United States
ISIN
US6989551014
Listings
0 Comments
Share your thoughts
FAQs
What is Parabilis Medicines stock price today?▼
The current price of PBLS is $28.32 USD — it has decreased by -1.32% in the past 24 hours. Watch Parabilis Medicines stock price performance more closely on the chart.
What is Parabilis Medicines stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Parabilis Medicines stocks are traded under the ticker PBLS.
What is Parabilis Medicines market cap?▼
Today Parabilis Medicines has the market capitalization of 3.5B
When is the next Parabilis Medicines earnings date?▼
Parabilis Medicines is going to release the next earnings report on December 2, 2026.
What were Parabilis Medicines earnings last quarter?▼
PBLS earnings for the last quarter are -2.32 USD per share, whereas the estimation was -0.17 USD resulting in a -1,306.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Parabilis Medicines revenue for the last year?▼
Parabilis Medicines revenue for the last year amounts to 0 USD.
What is Parabilis Medicines net income for the last year?▼
PBLS net income for the last year is -186.93M USD.
How many employees does Parabilis Medicines have?▼
As of November 1, 2026, the company has 145 employees.
In which sector is Parabilis Medicines located?▼
Parabilis Medicines operates in the Health & Wellness sector.
When did Parabilis Medicines complete a stock split?▼
Parabilis Medicines has not had any recent stock splits.
Where is Parabilis Medicines headquartered?▼
Parabilis Medicines is headquartered in CAMBRIDGE, United States.